Resources

News – February 27, 2025

On February 4, 2025, the Delaware Supreme Court overturned a Superior Court decision finding an SEC investigation and securities class action involving Alexion Pharmaceuticals, Inc. to be unrelated. 

Continue Reading

News – December 5, 2023

KBR partner Scott A. Schechter moderated a panel on, “Concerning Risk Trends in Public Company D&O and FI”, at the PLUS Conference in Las Vegas.

Continue Reading